Medovia Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 4.17 Cr
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
About Medovia Pharmaceuticals
Medovia Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 2018 (Six years and eight months 4 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subhash Chand and Md Enayatullah serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52609DL2018PTC335669
- Company No.
335669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medovia Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Chand  | Additional Director | 28-Jun-2024 | Current |
| Md Enayatullah | Additional Director | 18-Jul-2024 | Current |
Financial Performance of Medovia Pharmaceuticals.
Enhance accessibility to Medovia Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medovia Pharmaceuticals?
Unlock access to Medovia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Seraphic Fashion Retail Private LimitedMd Enayatullah is a mutual person
Saamag Projects LimitedSubhash Chand is a mutual person
Pyramid Realtors Private LimitedSubhash Chand is a mutual person
- Saga Developers Private Limited
Subhash Chand is a mutual person
- Saamag International Private Limited
Subhash Chand is a mutual person
- Saamag Royal Hospitality Private Limited
Subhash Chand is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medovia Pharmaceuticals?
Unlock and access historical data on people associated with Medovia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medovia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medovia Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
